Anuh Pharma peers

Companies like Anuh Pharmalatest year

Market cap and P/E at the last close; sales growth is the latest quarter on the same quarter a year before; ROE for the latest financial year.

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

ANUHPHR₹79.61

Anuh Pharma Limited

· Pharma & Health
₹ CrorePeersAHCLWANBURYZIMLABBAJAJHCARETHEMISMEDLINCOLNVALIANTLABSIGACHIMcap ₹798 Cr
Comp Set
In ₹ Crore except Per Share
Latest Annual
ANUHPHR
FY26
AHCL
FY26
WANBURY
FY25
ZIMLAB
FY26
Peer
Average
Valuation — at last close
P/E19.42×◆ 4.00×18.69×118.71×47.13× -59%
P/B2.27×◆ 0.56×9.63×2.55×4.25× -47%
EV/EBITDA12.07×◆ 4.08×9.58×27.83×13.83× -13%
Market Cap₹798 Cr₹130 Cr₹571 Cr₹756 Cr₹486 Cr +64%
Growth
Revenue CAGR 3Y——◆ 5.46%-2.06%1.70%
Revenue CAGR 5Y——10.29%—10.29%
Net Income CAGR 3Y——◆ -27.91%-37.95%-32.93%
Revenue YoY (latest Q)3.93%—24.47%◆ 31.25%27.86% -86%
Net Income YoY (latest Q)37.63%—◆ 1200.41%-114.25%543.08% -93%
Profitability
EBITDA Margin8.00%◆ 27.63%12.73%8.02%16.13% -50%
Net Income Margin5.32%◆ 16.92%5.09%1.56%7.86% -32%
Return on Common Equity12.10%12.38%◆ 70.01%2.13%28.17% -57%
Return on Capital Employed14.75%17.26%◆ 34.18%3.06%18.17% -19%
Return on Assets7.72%7.78%◆ 8.06%1.15%5.66% +36%
Credit & Quality
Total Debt/Equity◆ 0.00×0.17×2.92×0.42×1.17× -100%
Interest Coverage◆ 106.58×12.30×1.71×0.76×4.92× +2065%
Scale — latest FY
Revenue / Total Income₹772 Cr₹172 Cr₹600 Cr₹374 Cr₹382 Cr +102%
Net Income₹41 Cr₹29.1 Cr₹30.5 Cr₹5.8 Cr₹21.8 Cr +88%
Total Assets₹557 Cr₹374 Cr₹414 Cr₹539 Cr₹442 Cr +26%
EPS₹4.1₹6.11₹9.32₹1.19₹5.54 -26%
Book Value per Share₹35.14₹43.32₹18.09₹55.36₹38.92 -10%
◆ best value in the comp set per metric · Δ = subject vs average of the other companies.
« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.